A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.
1) Phase II study showed effects of short-term green tea use on prostate cancer; 2) Green tea reduced incidence, progression of prostate cancer; 3) Right combination of polyphenols can slow prostate cancer growth.
The University of San Pablo CEU, a major academic and research institution in Madrid, Spain, today presented Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research, with an honorary doctorate in medicine that recognizes her exceptional contributions to cancer research and leadership of the AACR, which have done so much to help those suffering from cancer.
Stand Up To Cancer (SU2C), the charitable initiative supporting groundbreaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, has reached a significant milestone, awarding the first round of three-year grants "“ that total $73.6 million -- to five multi-disciplinary, multi-institutional research Dream Teams. The majority of these funds were raised in connection with an SU2C telecast on September 5, 2008 that aired simultaneously on the ABC, CBS and NBC networks.
The American Association for Cancer Research held its 100th Annual Meeting in Denver, Colo., in April and drew more than 15,000 people from all over the world to network and learn about the latest breakthroughs in scientific cancer research.
Meat cooked at high temperatures to the point of burning and charring may increase the risk of pancreatic cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Researchers may have found a way to combine imaging with chemotherapy in a single agent for the treatment of prostate cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Walnut consumption may provide the body with essential omega-3 fatty acids, antioxidants and phytosterols that reduce the risk of breast cancer, according to a study presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Pre-diagnostic wine consumption may reduce the risk of death and relapse among non-Hodgkin's lymphoma patients, according to an epidemiology study presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Knowledge of the human genome continues to provide tools in the fight against cancer as scientists work to understand diagnosis and prognosis at earlier stages. Data presented at the AACR 100th Annual Meeting 2009 illustrate this progress.
New genetic research suggests that the traditional risk factors for melanoma may not be as helpful in predicting risk in all people as previously thought, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Although progress has been made on several fronts, minority cancer populations still experience higher risk and poorer cancer outcomes. At the AACR 100th Annual Meeting 2009, Elena Martinez, Ph.D., M.P.H, professor of epidemiology and biostatistics at the University of Arizona Cancer Center, will moderate a press conference on Racial and Ethnic Disparities in Cancer Care Delivery that will address these issues. Martinez is a previous chair of AACR's Science of Cancer Health Disparities Conference.
Genetic variations in the inflammation pathway may predict who would respond to Bacillus-Calmette-Guerin (BCG) treatment and who might experience a recurrence among patients with non-muscle invasive bladder cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
The American Association for Cancer Research remains committed to cancer prevention. Peter G. Shields, M.D., deputy director of the Lombardi Comprehensive Cancer Center and interim chair of the department of medicine at Georgetown University Medical Center, will host a press conference at the AACR 100th Annual Meeting 2009 that highlights recent breakthroughs.
As part of its efforts to showcase the latest breakthroughs in cancer science, the American Association for Cancer Research will host a press conference highlighting the newest research and clinical trial results from the AACR 100th Annual Meeting 2009.
The Annual Meeting of the American Association for Cancer Research remains the premier destination to showcase the newest and most exciting developments in cancer prevention and treatment. At the AACR 100th Annual Meeting 2009, Pasi A. Janne, M.D., Ph.D., an assistant professor of medicine at Harvard Medical School in Boston, will host a press conference that will highlight cutting-edge research.
Pancreatic cancer remains one of the deadliest cancers, but researchers may have found a combination therapy to reduce cancer stem cells and stop pancreatic cancer growth. Results will be presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Treatment with biphosphonates could prevent radiation-induced leukemia, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
Researchers may have uncovered why lung cancer afflicts some smokers and not others, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
John E. Niederhuber, M.D., director of the National Cancer Institute (NCI), part of the National Institutes of Health, will address the American Association for Cancer Research 100th Annual Meeting 2009 in Denver Monday, April 20, 2009, during a Special Session. The talk will focus on opportunities to hasten our progress against cancer and to conduct exciting new science, made possible, in part, by NCI's nearly three percent budget increase this year.
The American Association for Cancer Research (AACR) is offering teleconference lines for media interested in participating in the press briefings scheduled during its AACR 100th Annual Meeting 2009, April 18-22 in Denver, Colorado. Following the briefings, the phone lines will be opened for question and answer sessions.
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
Cutting-edge breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when nearly 17,000 scientists from around the world gather at the Colorado Convention Center, April 18-22, for the AACR 100th Annual Meeting 2009. Key data presented at the meeting will include new advances in personalized medicine that have demonstrated significant patient benefit.
In commemoration of 100 years of progress in cancer research, the American Association for Cancer Research will present Kathy Giusti and Nicholas P. (Nick) Valvano with the AACR Centennial Medal for Distinguished Public Service at the opening ceremony of its 100th Annual Meeting 2009 on Sunday, April 19.
The 3rd Annual American Association for Cancer Research Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research will be presented to Anna D. Barker, Ph.D., deputy director of the National Cancer Institute (NCI).
The American Association for Cancer Research and the Kirk A. and Dorothy P. Landon Foundation will award the 2nd Annual INNOVATOR Award for Cancer Prevention Research to Gregory P. Tochtrop, Ph.D., assistant professor of chemistry at Case Western Reserve University in Cleveland. The award for International Collaboration will be presented to Josep M. Llovet, M.D., professor of research at the Institut d'Investigacions Biomediques August Pi Sunyer Hospital Clinic in Barcelona, Spain, for the work of the Hepatocellular Carcinoma Genomic Consortium.
The American Association for Cancer Research (AACR) and the Kirk A. and Dorothy P. Landon Foundation announced the winners of the 2009 prizes for basic and translational cancer research. This year's Kirk A. Landon-AACR Prize for Basic Cancer Research will be jointly awarded to Peter A. Jones, Ph.D., D.Sc., director of the University of Southern California/Norris Comprehensive Cancer Center and distinguished professor of urology, biochemistry and molecular biology at the Keck School of Medicine and Stephen B. Baylin, M.D., professor of oncology at Johns Hopkins University. The Dorothy P. Landon-AACR Prize for Translational Cancer Research will be awarded to Charles L. Sawyers, M.D., investigator at the Howard Hughes Medical Institute and chairman of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center.
Joseph F. Fraumeni, Jr., M.D., M.Sc., recognized worldwide for his seminal research contributions in understanding the causes and prevention of human cancer, will receive the American Association for Cancer Research Award for Lifetime Achievement in Cancer Research. For more than 30 years, Fraumeni has led one of the premier cancer epidemiology groups in the world at the National Cancer Institute, and he has helped mentor and train the next generation of interdisciplinary scientists.
The world's leading cancer researchers whose science has significantly contributed to progress in the fight against cancer will be recognized by the American Association for Cancer Research at its 100th Annual Meeting at the Colorado Convention Center.
As part of the AACR 100th Annual Meeting 2009, the American Association for Cancer Research will recognize leaders in the minority cancer community with the Minority-Serving Institution Faculty Scholars in Cancer Research Awards and the Minority Scholars in Cancer Research.
Napoleone Ferrara, M.D., is the recipient of the 2009 Pezcoller Foundation-AACR International Award for Cancer Research for his groundbreaking research in the mechanisms of tumor angiogenesis, which ranges from pioneering basic science to creating novel therapies.
The American Association for Cancer Research will award a Centennial Medal for Distinguished Public Service to the members of the Stand Up To Cancer Executive Leadership Council at the opening ceremony of the AACR's 100th Annual Meeting 2009 on Sunday, April 19.
The third annual American Association for Cancer Research Team Science Award will be given to a multidisciplinary group of researchers representing the St. Jude Children's Research Hospital Acute Lymphoblastic Leukemia Team at the AACR 100th Annual Meeting 2009 at the Colorado Convention Center in Denver, Colo. This award recognizes an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or will likely advance cancer research, detection, diagnosis, prevention or treatment.
The American Association for Cancer Research will honor Senator Arlen Specter of Pennsylvania with a Centennial Award for Distinguished Public Service. At the AACR 100th Annual Meeting 2009, Specter will address the meeting with a live video transmission at the opening ceremony on Sunday, April 19, 2009, at 8:15 a.m. MST.
In an effort to educate and inspire the future cancer researchers of America, the American Association for Cancer Research is holding several programs for high school and undergraduate college students who are embarking on a career in science. This program, sponsored by the AACR Science Education Committee, will take place at the AACR 100th Annual Meeting 2009.
The members of the American Association for Cancer Research have elected Elizabeth H. Blackburn, Ph.D., Morris Herzstein professor of biology and physiology at the University of California, San Francisco, as their president-elect.
Three-day-old broccoli sprouts, a widely available human food, suppressed Helicobacter pylori (H. pylori) infections, according to a report in Cancer Prevention Research, a journal of the American Association for Cancer Research. H. pylori infections are one of the most common bacterial infections worldwide and are a major cause of stomach cancer.
In 2007, in a bipartisan show of support for cancer research, the United States Congress declared May as National Cancer Research Month. Senate Resolution 394 was sponsored by Sen. Arlen Specter (R-PA), Sen. Diane Feinstein (D-CA) and Sen. Ted Stevens (R-AK). House Resolution 448 was sponsored by Rep. Jim Matheson (D-UT) with support from Rep. Vito Fossella (R-NY), Rep. Joe Baca (D-CA) and Rep. Tammy Baldwin (D-WI). Both resolutions passed with unanimous consent.
Researchers have identified a possible genetic cause for increased risk for a more advanced form of colorectal cancer in blacks that leads to shorter survival, according to data published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
On Thursday, Senators Edward M. Kennedy and Kay Bailey Hutchison introduced legislation that will renew the war on cancer by modernizing and advancing the national cancer program of the United States.
Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research (AACR), today received the inaugural Margaret Kripke Legend Award from The University of Texas M. D. Anderson Cancer Center.
Asian-American women who ate higher amounts of soy during childhood had a 58 percent reduced risk of breast cancer, according to a study published in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
Omega-3 fatty acids appear protective against advanced prostate cancer, and this effect may be modified by a genetic variant in the COX-2 gene, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
The American Association for Cancer Research extends its sincere congratulations to Margaret Hamburg, M.D., on her nomination to lead the Food and Drug Administration (FDA).
The 100th AACR Annual Meeting 2009 features the latest findings in laboratory, translational and clinical cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing cancer.
Consuming two or more drinks per day could increase a person's risk of pancreatic cancer by about 22 percent, according to data published in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate cancer, according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Following the passage of the American Recovery and Investment Act of 2009 by Congress, the American Association for Cancer Research praised Republican Senator Arlen Specter of Pennsylvania for his leadership in including a $10 billion investment in the National Institutes of Health (NIH).
Arizona has the ability to expand colorectal cancer screening capacity; this potential increase was more pronounced in rural as compared to urban regions, according to data presented at the American Association for Cancer Research conference on the Science of Cancer Health Disparities.
As science continues to show an increasing lack of access and poor outcomes among minority patients with cancer, the American Association for Cancer Research is working toward understanding the fundamental issues of trust and awareness among these populations. At the Conference on the Science of Cancer Health Disparities in Carefree, Arizona, the AACR will host a teleconference that highlights important strides in this area.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right